DWP709

N/A

Report date: 2024/11/26 16:13:27

Base Information

Drug NameDWP709
Drug Alias NameDWP709DWP-818-1
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionEpidermal growth factor receptor erbB1 agonists
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsEpidermolysis Bullosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaewoong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsEpidermolysis Bullosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A